Fosaprepitant metaboliseres i forskellige ekstrahepatiske væv; leverinsufficiens forventes derfor ikke at ændre omdannelsen af fosaprepitant til aprepitant.
Fosaprepitant is metabolized in various extrahepatic tissues; therefore hepatic insufficiency is not expected to alter the conversion of fosaprepitant to aprepitant.